Arthritis News and Research

Latest Arthritis News and Research

IPC investigating relationship between BMI and severity of psoriasis in childhood

As people around the world get ready to participate in events for World Psoriasis Day on October 29, the International Psoriasis Council (IPC) is nearing completion with enrollment in a multi-center study on the relationship between obesity and psoriasis in children. The theme of this year’s World Psoriasis Day is childhood psoriasis.

28 Oct 2010

Marital adjustment associated with better health status for RA patients

Rheumatoid arthritis is a painful and debilitating condition, but a study reported in The Journal of Pain, published by the American Pain Society, shows that being in a strong, non-distressed marriage is associated with experiencing less pain and enjoying better functioning and quality of life.

27 Oct 2010

Bristol-Myers Squibb 2010 third quarter U.S. net sales increases 4% to $3.1 billion

Bristol-Myers Squibb Company today reported results for the third quarter of 2010. Highlights in the quarter included: the presentation of new data on investigational compounds in the diabetes and cardiovascular disease franchises at major medical meetings; the completion of important regulatory milestones in the oncology, diabetes and immunoscience franchises; the acquisition of ZymoGenetics; and double-digit EPS growth. The company also confirmed guidance for 2010.

26 Oct 2010

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

Biogen Idec Inc. a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its third quarter 2010 results.

26 Oct 2010

Survey highlights emotional impact of psoriasis on school children

Almost half of children with psoriasis surveyed by the National Psoriasis Foundation report being bullied at least once in the last six months. The Psoriasis Foundation surveyed parents of kids with psoriatic disease and found that 44 percent of children have been bullied by their peers, and 38 percent of kids say the abuse was a direct result of their disease.

26 Oct 2010

Phase II data from resminostat SAPHIRE study to be presented at International Hodgkin Lymphoma Symposium

4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the presentation of Phase II data from Hodgkin Lymphoma patients treated in the 1st Simon Stage cohort of the ongoing SAPHIRE study with resminostat (4SC-201), an oral pan-histone deacetylase (HDAC) inhibitor, at the 8th International Symposium on Hodgkin Lymphoma in Cologne, Germany.

26 Oct 2010

La Jolla Institute scientist wins Malpighi Medal for pioneering work in heart disease

Klaus Ley, M.D, a scientist at the La Jolla Institute for Allergy & Immunology, was recently awarded the prestigious Malpighi Medal at the World Congress for Microcirculation in Paris, France. A lifetime achievement award presented by the European Society for Microcirculation, Dr. Ley received the honor in recognition of his pioneering endeavors in vascular immunology, a scientific discipline that he helped to pioneer, which looks at novel immune-based approaches to combating heart disease. He is only the 17th recipient of the biennial award worldwide.

26 Oct 2010

Celtic, Resolvyx enter option agreement for RX-10045 to treat dry eye syndrome

Celtic Therapeutics Holdings L.P. a successor firm to Celtic Pharma, and Resolvyx Pharmaceuticals, Inc. (Resolvyx) announced today that they have entered into an option agreement relating to Resolvyx's RX-10045, a late-stage program for the treatment of dry eye syndrome and other ophthalmic conditions.

26 Oct 2010

Amgen reports $3,816 million for 2010 third quarter revenue

Amgen reported revenue unchanged for the third quarter of 2010 at $3,816 million versus $3,812 million for the third quarter of 2009.

26 Oct 2010

Diabetics living in adverse neighborhood conditions more likely to develop lower body functional limitations

A study published earlier this year in the peer reviewed online journal BMC Public Health has found that residing in a neighborhood with adverse living conditions such as low air quality, loud traffic or industrial noise, or poorly maintained streets, sidewalks and yards, makes mobility problems much more likely in late middle-aged African Americans with diabetes.

25 Oct 2010

ISTSS to honor Vietnam veteran with Lifetime Achievement Award

Joseph Boscarino, Ph.D, M.P.H.,will be recognized by the International Society of Traumatic Stress (ISTSS) with a Lifetime Achievement Award for his contributions to the research of traumatic stress.

25 Oct 2010

Experts agree on key policy recommendations for management, prevention of rheumatic, MSKD

On 19 October 2010, experts from academia, scientific societies, patient organisations, Member States' government and social security institutions as well as EU bodies agreed upon a number of key policy recommendations for improving the management and prevention of rheumatic and musculoskeletal diseases.

22 Oct 2010

$Medtronic's Xpander II receives FDA clearance for vertebral compression fractures$

Medtronic's Xpander II receives FDA clearance for vertebral compression fractures

Medtronic Inc. today announced Food and Drug Administration (FDA) clearance of the Kyphon Xpander II Inflatable Bone Tamp (IBT) for the treatment of vertebral compression fractures with minimally invasive Kyphon Balloon Kyphoplasty

22 Oct 2010

Biogen, Genentech announce new structure of anti-CD20 collaboration

Biogen Idec and Genentech, Inc. a wholly owned member of the Roche Group today announced that they have agreed to amend their collaboration on antibodies targeting CD20.

22 Oct 2010

Idera announces IMO-3100 Phase 1 clinical trial results for autoimmune disease

Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.

22 Oct 2010

Health Canada approves ULORIC to lower serum uric acid levels in patients with gout

Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.

21 Oct 2010

Highlights of Frontiers in Optics 2010/Laser Science XXVI Meeting

Scientists and engineers from around the world will gather on the shores of Lake Ontario in Rochester, N.Y. next week to discuss some of the latest breakthroughs in lasers and optics and their applications to cutting-edge science, the development of new materials, and medicine.

21 Oct 2010

Bonati Spine Institute supports National Breast Cancer Awareness

The Bonati Spine Institute, the leading center for the patented Bonati Spine Procedures for minimally invasive laser spine surgery, is a strong supporter of National Breast Cancer Awareness.

21 Oct 2010

Empire announces launch of Patient Centered Medical Home pilot

For many people with chronic health conditions, it can be tough to navigate through the complex healthcare system. Mary, a 65 year old woman with several conditions including diabetes, arthritis, high blood pressure and high cholesterol, visits specialists for each of these conditions - an endocrinologist, rheumatologist and cardiologist - in addition to her primary care physician.

21 Oct 2010

Lubricin reduces wear to bone cartilage

A team of researchers in North Carolina has discovered that lubricin, a synovial fluid glycoprotein, reduces wear to bone cartilage. This result, which has implications for the treatment of sufferers of osteoarthritis, will be presented today at the AVS 57th International Symposium & Exhibition, taking place this week at the Albuquerque Convention Center in New Mexico.

21 Oct 2010

Arthritis News and Research

Latest Arthritis News and Research

IPC investigating relationship between BMI and severity of psoriasis in childhood

Marital adjustment associated with better health status for RA patients

Bristol-Myers Squibb 2010 third quarter U.S. net sales increases 4% to $3.1 billion

Biogen 2010 third quarter revenue increase 5% to $1.2 billion

Survey highlights emotional impact of psoriasis on school children

Phase II data from resminostat SAPHIRE study to be presented at International Hodgkin Lymphoma Symposium

La Jolla Institute scientist wins Malpighi Medal for pioneering work in heart disease

Celtic, Resolvyx enter option agreement for RX-10045 to treat dry eye syndrome

Amgen reports $3,816 million for 2010 third quarter revenue

Diabetics living in adverse neighborhood conditions more likely to develop lower body functional limitations

ISTSS to honor Vietnam veteran with Lifetime Achievement Award

Experts agree on key policy recommendations for management, prevention of rheumatic, MSKD

Medtronic's Xpander II receives FDA clearance for vertebral compression fractures

Biogen, Genentech announce new structure of anti-CD20 collaboration

Idera announces IMO-3100 Phase 1 clinical trial results for autoimmune disease

Health Canada approves ULORIC to lower serum uric acid levels in patients with gout

Highlights of Frontiers in Optics 2010/Laser Science XXVI Meeting

Bonati Spine Institute supports National Breast Cancer Awareness

Empire announces launch of Patient Centered Medical Home pilot

Lubricin reduces wear to bone cartilage

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Arthritis News and Research

Latest Arthritis News and Research

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in